These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23261466)

  • 21. Binding of apolipoprotein A-I model peptides to lipid bilayers. Measurement of binding isotherms and peptide-lipid headgroup interactions.
    Spuhler P; Anantharamaiah GM; Segrest JP; Seelig J
    J Biol Chem; 1994 Sep; 269(39):23904-10. PubMed ID: 7929037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-terminus of apolipoprotein A-I removes phospholipids from a triolein/phospholipids/water interface, but the N-terminus does not: a possible mechanism for nascent HDL assembly.
    Mitsche MA; Small DM
    Biophys J; 2011 Jul; 101(2):353-61. PubMed ID: 21767487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I.
    Van Lenten BJ; Wagner AC; Jung CL; Ruchala P; Waring AJ; Lehrer RI; Watson AD; Hama S; Navab M; Anantharamaiah GM; Fogelman AM
    J Lipid Res; 2008 Nov; 49(11):2302-11. PubMed ID: 18621920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.
    Huang Y; Wu Z; Riwanto M; Gao S; Levison BS; Gu X; Fu X; Wagner MA; Besler C; Gerstenecker G; Zhang R; Li XM; DiDonato AJ; Gogonea V; Tang WH; Smith JD; Plow EF; Fox PL; Shih DM; Lusis AJ; Fisher EA; DiDonato JA; Landmesser U; Hazen SL
    J Clin Invest; 2013 Sep; 123(9):3815-28. PubMed ID: 23908111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux.
    Rosenblat M; Gaidukov L; Khersonsky O; Vaya J; Oren R; Tawfik DS; Aviram M
    J Biol Chem; 2006 Mar; 281(11):7657-65. PubMed ID: 16407304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.
    Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Handattu SP; Mishra VK; Anantharamaiah GM
    Atherosclerosis; 2012 Oct; 224(2):326-31. PubMed ID: 22771190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein A-I mimetic peptides.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Yu N; Ansell BJ; Datta G; Garber DW; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1325-31. PubMed ID: 15831812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage paraoxonase 1 (PON1) binding sites.
    Efrat M; Aviram M
    Biochem Biophys Res Commun; 2008 Nov; 376(1):105-10. PubMed ID: 18762170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide.
    Wool GD; Vaisar T; Reardon CA; Getz GS
    J Lipid Res; 2009 Sep; 50(9):1889-900. PubMed ID: 19433476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism.
    Deakin S; Leviev I; Gomaraschi M; Calabresi L; Franceschini G; James RW
    J Biol Chem; 2002 Feb; 277(6):4301-8. PubMed ID: 11726658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis.
    Zamanian-Daryoush M; Gogonea V; DiDonato AJ; Buffa JA; Choucair I; Levison BS; Hughes RA; Ellington AD; Huang Y; Li XS; DiDonato JA; Hazen SL
    J Biol Chem; 2020 Apr; 295(15):4836-4848. PubMed ID: 32098873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia.
    Liu ML; James RW; Ylitalo K; Taskinen MR
    Nutr Metab Cardiovasc Dis; 2004 Apr; 14(2):81-7. PubMed ID: 15242240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress.
    Moren X; Deakin S; Liu ML; Taskinen MR; James RW
    J Lipid Res; 2008 Jun; 49(6):1246-53. PubMed ID: 18314464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
    Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and Functional Impairments of Reconstituted High-Density Lipoprotein by Incorporation of Recombinant β-Amyloid42.
    Cho KH
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F.
    White CR; Datta G; Buck AK; Chaddha M; Reddy G; Wilson L; Palgunachari MN; Abbasi M; Anantharamaiah GM
    J Lipid Res; 2012 Aug; 53(8):1576-87. PubMed ID: 22589558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein A-II-mediated conformational changes of apolipoprotein A-I in discoidal high density lipoproteins.
    Gauthamadasa K; Vaitinadin NS; Dressman JL; Macha S; Homan R; Greis KD; Silva RA
    J Biol Chem; 2012 Mar; 287(10):7615-25. PubMed ID: 22235130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The conformation of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. 13C NMR studies of lysine ionization behavior.
    Sparks DL; Phillips MC; Lund-Katz S
    J Biol Chem; 1992 Dec; 267(36):25830-8. PubMed ID: 1464597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity.
    James RW; Deakin SP
    Free Radic Biol Med; 2004 Dec; 37(12):1986-94. PubMed ID: 15544917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.